Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Boeree

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Drug and Chemical Toxicology|May 1, 2010
Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cellsAlma Tostmann, Rob E Aarnoutse, Wilbert H M Peters, et al.
The Journal of Antimicrobial Chemotherapy|November 11, 2009
Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatmentJossy van den Boogaard, Hadija H Semvua, Martin J Boeree, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 18, 2021
Early COVID-19 pandemic's toll on tuberculosis services, WHO European Region, January to June 2020Masoud Dara, Giorgi Kuchukhidze, Askar Yedilbayev, et al.
Emerging Infectious Diseases|April 4, 2012
Characterization of Mycobacterium orygis as M. tuberculosis complex subspeciesJakko van Ingen, Zeaur Rahim, Arnout Mulder, et al.
Veterinary Microbiology|January 26, 2010
Isolation of mycobacteria other than Mycobacterium avium from porcine lymph nodesJakko van Ingen, Henk J Wisselink, Conny B van Solt-Smits, et al.
Therapeutic Drug Monitoring|June 20, 2014
Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settingsHadija H Semvua, Gibson S Kibiki, Elton R Kisanga, et al.
International Journal of Antimicrobial Agents|April 7, 2009
In vitro activity of thioridazine against mycobacteriaJakko van Ingen, Tridia van der Laan, Leonard Amaral, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial diseaseJakko van Ingen, Sarah E Totten, Niels K Helstrom, et al.
Journal of Clinical Microbiology|July 2, 2010
High-resolution typing by integration of genome sequencing data in a large tuberculosis clusterAnita C Schürch, Kristin Kremer, Olaf Daviena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2019
Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band DosingBudi O Susanto, Robin J Svensson, Elin M Svensson, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Drug and Chemical Toxicology|May 1, 2010
Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cellsAlma Tostmann, Rob E Aarnoutse, Wilbert H M Peters, et al.
The Journal of Antimicrobial Chemotherapy|November 11, 2009
Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatmentJossy van den Boogaard, Hadija H Semvua, Martin J Boeree, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 18, 2021
Early COVID-19 pandemic's toll on tuberculosis services, WHO European Region, January to June 2020Masoud Dara, Giorgi Kuchukhidze, Askar Yedilbayev, et al.
Emerging Infectious Diseases|April 4, 2012
Characterization of Mycobacterium orygis as M. tuberculosis complex subspeciesJakko van Ingen, Zeaur Rahim, Arnout Mulder, et al.
Veterinary Microbiology|January 26, 2010
Isolation of mycobacteria other than Mycobacterium avium from porcine lymph nodesJakko van Ingen, Henk J Wisselink, Conny B van Solt-Smits, et al.
Therapeutic Drug Monitoring|June 20, 2014
Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settingsHadija H Semvua, Gibson S Kibiki, Elton R Kisanga, et al.
International Journal of Antimicrobial Agents|April 7, 2009
In vitro activity of thioridazine against mycobacteriaJakko van Ingen, Tridia van der Laan, Leonard Amaral, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial diseaseJakko van Ingen, Sarah E Totten, Niels K Helstrom, et al.
Journal of Clinical Microbiology|July 2, 2010
High-resolution typing by integration of genome sequencing data in a large tuberculosis clusterAnita C Schürch, Kristin Kremer, Olaf Daviena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2019
Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band DosingBudi O Susanto, Robin J Svensson, Elin M Svensson, et al.
Pageof 13